Resultados globales: 6 registros encontrados en 0.01 segundos.
Artículos, Encontrados 6 registros
Artículos Encontrados 6 registros  
1.
6 p, 559.6 KB Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients : final results of the Spanish BOC HIV-HCV Study / Laguno Centeno, Montserrat (Hospital Clínic i Provincial de Barcelona) ; Von Wichmann, M.A. (Hospital de Donostia (Sant Sebastià, País Basc)) ; Van den Eynde, E. (Hospital Universitari de Bellvitge) ; Navarro, J. (Hospital Universitari Vall d'Hebron) ; Cifuentes, C. (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Murillas, J. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Veloso, S. (Hospital Universitari Joan XXIII de Tarragona) ; Martínez-Rebollar, M. (Hospital Clínic i Provincial de Barcelona) ; Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdica Sant Pau) ; Jou, A. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gómez-Sirvent, J.L. (Hospital Universitario de Canarias (La Laguna)) ; Cervantes, Manuel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Pineda, J.A. (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; López-Calvo, S. (Complejo Hospitalario Universitario de A Coruña) ; Carrero, A. (Hospital General Universitario Gregorio Marañón) ; Montes, M.L. (Hospital Universitario La Paz (Madrid)) ; Deig, E. (Hospital General de Granollers) ; Tapiz, A. (Fundació Althaia) ; Ruiz-Mesa, J.D. (Hospital Regional) ; Cruceta, A. (Hospital Clínic i Provincial de Barcelona) ; de Lazzari, E. (Hospital Clínic i Provincial de Barcelona) ; Mallolas, J. (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Boceprevir (BOC) was one of the first oral inhibitors of hepatitis C virus (HCV) NS3 protease to be developed. This study assessed the safety and efficacy of BOC + pegylated interferon-α2a/ribavirin (PEG-IFN/RBV) in the retreatment of HIV-HCV co-infected patients with HCV genotype 1. [...]
2016 - 10.1016/j.ijid.2016.10.028
International journal of infectious diseases, Vol. 53 (january 2016) , p. 46-51  
2.
13 p, 276.7 KB Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection / Berenguer, Juan (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Rodríguez-Castellano, Elena (Hospital Universitario La Paz (Madrid)) ; Carrero, Ana (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; Von Wichmann, Miguel A. (Hospital de Donostia (Sant Sebastià, País Basc)) ; Montero, Marta (Hospital Universitari i Politècnic La Fe (València)) ; Galindo, María J. (Hospital Clínico Universitario) ; Mallolas, Josep (Hospital Clínic i Provincial de Barcelona) ; Crespo Casal, Manuel (Complexo Hospitalario Universitario de Vigo) ; Téllez, María J. (Hospital Clínico San Carlos (Madrid)) ; Quereda, Carmen (Hospital Universitario Ramón y Cajal (Madrid)) ; Sanz, José (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ; Barros, Carlos (Hospital Universitario de Móstoles (Madrid)) ; Tural, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santos, Ignacio (Hospital Universitario de la Princesa (Madrid)) ; Pulido, Federico (Hospital Universitario 12 de Octubre (imas12)) ; Guardiola Tey, Jose Maria (Institut d'Investigació Biomèdica Sant Pau) ; Rubio, Rafael (Hospital Universitario 12 de Octubre (imas12)) ; Ortega, Enrique (Hospital General Universitario) ; Montes, María L. (Hospital Universitario La Paz (Madrid)) ; Jusdado, Juan J. (Hospital Universitario Severo Ochoa) ; Gaspar, Gabriel (Hospital Universitario de Getafe (Madrid)) ; Esteban, Herminia (Fundación SEIMC-GESIDA) ; Bellón, José M. (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ; González-García, Juan (Hospital Universitario La Paz (Madrid)) ; Universitat Autònoma de Barcelona
We assessed non-liver-related non-acquired immunodeficiency syndrome (AIDS)-related (NLR-NAR) events and mortality in a cohort of human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients treated with interferon (IFN) and ribavirin (RBV), between 2000 and 2008. [...]
2017 - 10.1002/hep.29071
Hepatology, Vol. 66 Núm. 2 (august 2017) , p. 344-356  
3.
13 p, 2.2 MB High circulating SDF-1and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5 : Prognostic signature of immune recovery status in treated HIV-positive patients / Yeregui, Elena (Institut d'Investigació Sanitària Pere Virgili) ; Viladés, Consuelo (Institut d'Investigació Sanitària Pere Virgili) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Ceausu, Andra (Universitat Rovira i Virgili) ; Pacheco, Yolanda María (Universidad de Sevilla) ; Veloso, Sergi (Universitat Rovira i Virgili) ; Inciarte, Alexy (Hospital Clínic i Provincial de Barcelona) ; Vidal-González, Judit (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Peraire, Maria (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Perpiñán, Carles (CAP Sant Pere) ; Falcó, Vicenç (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Masip, Jenifer (Universitat Rovira i Virgili) ; Alba Elvira, Veronica (Universitat Rovira i Virgili) ; Vargas Laguna, Montserrat (Universitat Rovira i Virgili) ; Martí, Anna (Universitat Rovira i Virgili) ; Reverté Calvet, Laia (Universitat Rovira i Virgili) ; Mallolas Masferrer, Josep (Hospital Clínic i Provincial de Barcelona) ; Vidal, Francesc (Universitat Rovira i Virgili) ; Peraire, Joaquim (Universitat Rovira i Virgili) ; Rull, Anna (Universitat Rovira i Virgili) ; Universitat Autònoma de Barcelona
The underlying mechanisms of incomplete immune reconstitution in treated HIV-positive patients are very complex and may be multifactorial, but perturbation of chemokine secretion could play a key role in CD4 T-cell turnover. [...]
2020 - 10.1016/j.ebiom.2020.103077
EBioMedicine, Vol. 62 (december 2020) , p. 103077  
4.
12 p, 780.3 KB Observational cohort study of rilpivirine (RPV) utilization in Europe / Cozzi-Lepri, Alessandro (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ; Peters, Lars (CHIP. Rigshospitalet. University of Copenhagen) ; Pelchen-Matthews, Annegret (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ; Neesgaard, Bastian (CHIP. Rigshospitalet. University of Copenhagen (Belgium)) ; De Wit, Stéphane (Université Libre de Bruxelles, Department of Infectious Diseases) ; Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ; Edwards, Simon (Mortimer Market Centre, Department of HIV (London)) ; Stephan, Christoph (Infectious Diseases Unit. Goethe-University Hospital) ; Adamis, Georgios (General Hospital of Athens G. Gennimatas (Greece)) ; Staub, Therese (Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses (Luxembourg)) ; Zagalo, Alexandra (Santa Maria University Hospital, Department of Infectious Diseases (Lisbon, Portugal)) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Elbirt, Daniel (Allergy. Immunology and HIV Unit | Kaplan. Medical Center) ; Kusejko, Katharina (University Hospital Zürich (Switzerland)) ; Brännström, Johanna (Department of Infectious Diseases. Venhälsan Södersjukhuset) ; Paduta, Dzmitry (Gomel Regional Centre for Hygiene) ; Trofimova, Tatyana (Novgorod Centre for AIDS Prevention and Control) ; Szlavik, Janos (South-Pest Hospital Centre-National Institute for Infectiology and Haematology) ; Zilmer, Kai (West-Tallinn Central Hospital, Infectious Diseases Clinic (Talinn, Estonia)) ; Losso, Marcello (Hospital J.M. Ramos Mejia (Buenos Aires)) ; Van Eygen, Veerle (Janssen Research & Development) ; Pai, Helen (Janssen Research & Development) ; Lundgren, Jens (CHIP. Rigshospitalet. University of Copenhagen) ; Mocroft, Amanda (Rigshospitalet. University of Copenhagen (Denmark)) ; Harxhi, Arjan (Medical University of Tirana (Albania)) ; Losso, M. (Hospital General de Agudos JM Ramos Mejía) ; Kundro, Mariana (Hospital General de Agudos JM Ramos Mejía) ; Schmied, B. (Institute of Science and Technology Austria (ISTA)) ; Karpov, I. (Minsk State Linguistic University) ; Vassilenko, Anna (Médecins Sans Frontières) ; Paduto, D. ; Mitsura, Victor (Gomel State Medical University) ; Clumeck, Nathan (University Hospital Brussels) ; De Wit, S. (Université Libre de Bruxelles) ; Delforge, M. (Université Libre de Bruxelles) ; Hadziosmanovic, V. (Clinical Center University of Sarajevo) ; Begovac, Josip (University of Zagreb) ; Machala, L. (Charles University in Prague) ; Jilich, David (Charles University in Prague) ; Gerstoft, J. (IT University of Copenhagen) ; Torp-Pedersen, Christian (Aalborg Universitet) ; Sedlacek, Dalibor (Fakultní nemocnice Plzeň) ; Kronborg, Gitte (University of Copenhagen) ; Benfield, Thomas (Copenhagen University Hospital Hvidovre) ; Johansen, IS (Odense University Hospital (Dinamarca)) ; Ostergaard, Leif (Aarhus University) ; Wiese, Lothar (Roskilde University) ; Friis-Moller, Nina (Zealand University Hospital) ; Nielsen, L.N. ; Zilmer, K. (Kaunas University of Technology) ; Smidt, J. (Kohtla - Jarve Jarve Gümnaasium) ; Aho, Inka (Helsinki University Central Hospital) ; Viard, Jean-Paul (Université Paris Cité) ; Girard, Pierre-Marie (University of Paris-Est) ; Pradier, Christian (Centre Hospitalier Universitaire de Nice) ; Fontas, Eric (Centre Hospitalier Universitaire de Nice) ; Duvivier, Claudine (Hôpital Universitaire Necker) ; Rockstroh, Jurgen (Universitätsklinikum Bonn) ; Degen, Olaf (University Medical Center Hamburg) ; Hoffmann, C. ; Stellbrink, H.J. (ICH Study Center) ; Stefan, C. ; Bogner, Johannes (University Hospital München) ; Fätkenheuer, Gerd (University of Cologne) ; Chkhartishvili, N. (Infectious Diseases, AIDS and Clinical Immunology Research Center) ; Sambatakou, Helen (Hippokration General Hospital (Athens)) ; Adamis, Georgios ; Paissios, N. ; Uzdaviniene, V. (Vilnius University Hospital Santariškių Klinikos) ; Staub, T. (Centre Hospitalier de Luxembourg) ; Dragas, S. ; Reiss, P. (University of Amsterdam) ; Trajanovska, J. ; Reikvam, Dag Henrik (Oslo University Hospital (Oslo, Noruega)) ; Maeland, A. (Oslo University Hospital (Oslo, Noruega)) ; Bruun, Johan (University Hospital of North Norway) ; Knysz, B. (WWF Poland) ; Szetela, Bartosz (Nicolaus Copernicus University) ; Inglot, Malgorzata (Wroclaw Medical University) ; Bakowska, E. (Hospital For Infectious Diseases (Warsaw)) ; Flisiak, Robert (Medical University of Bialystok) ; Grzeszczuk, Anna (Medical University of Bialystok) ; Parczewski, Miłosz (Pomeranian Medical University in Szczecin) ; Maciejewska, Katarzyna (Pomeranian Medical University in Szczecin) ; Aksak-Was, Bogusz (Pomeranian Medical University in Szczecin) ; Beniowski, Marek (Medical University of Silesia in Katowice) ; Mularska, Elżbieta ; Jablonowska, Elżbieta (University of Lodz) ; Kamerys, J. ; Wojcik, K. (University of Lodz) ; Mozer-Lisewska, Iwona (Uniwersytet Medyczny im.Karola Marcinkowskiego w Poznaniu) ; Rozplochowski, Błażej (Poznan University of Medical Sciences) ; Zagalo, A. ; Radoi, Roxana (Clinical Hospital Of Infectious Diseases "Dr. Victor Babes") ; Oprea, Cris (Joint Institute for Nuclear Research) ; Yakovlev, A. (Saint Petersburg State University) ; Trofimora, T. ; Khromova, I. (Tomsk Regional Center of AIDS and infectious diseases prophylaxis and control" (RCAIDPC)) ; Kuzovatova, Elena (Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod) ; Borodulina, Elena ; Vdoushkina, Elena (Samara State Medical University) ; Ranin, Jovan (Klinički centar Srbije) ; Tomazic, J. (Ljubljana University Medical Centre) ; Miro, Josep M. (Instituto de Salud Carlos III) ; Laguno, Montse (Hospital Clínic i Provincial de Barcelona) ; Martinez, E. ; Garcia, F. ; Blanco, J.L. (Hospital Clínic i Provincial de Barcelona) ; Martinez-Rebollar, María (Hospital Clínic i Provincial de Barcelona) ; Mallolas, J. ; Callau, Pilar (Universitat de Barcelona) ; Rojas, J. (Hospital Clínic i Provincial de Barcelona) ; Moreno, Santiago (Pontifical Catholic University of Argentina) ; del Campo, Santos (Hospital Universitario Ramón y Cajal (Madrid)) ; Jou, A. (IrsiCaixa Institute for AIDS Research) ; Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Puig, Jordi (Universitat Autònoma de Barcelona) ; Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Santos, J.R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Gutierrez, M. ; Mateo, G.M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sambeat, A. ; Laporte, J.M. ; Svedhem, V. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Sonnerborg, A. ; Flamholc, L. (Skåne University Hospital (Suècia)) ; Kusejko, Katharina (University of Zurich) ; Weber, R. (Universitäts-Herzzentrum Freiburg - Bad Krozingen) ; Calmy, Alexandra (University of Geneva) ; Furrer, Hansjakob (Inselspital, Universitätsspital Bern) ; Battegay, Manuel (University of Basel) ; Schmid, P. (Cantonal Hospital of Schwyz) ; Kuznetsova, A. (Kyiv National Economic University) ; Mikhalik, Julia ; Sluzhynska, M. (International HIV/AIDS Alliance in Ukraine) ; Milinkovic, Ana (Imperial College London) ; Johnson, A.M. ; Simons, E. ; Edwards, S. (Brookhaven National Laboratory) ; Phillips, A.M. ; Johnson, A. (University of Colorado Boulder) ; Mocroft, A. ; Orkin, Chloe (Queen Mary, University of London) ; Winston, Alan (Imperial College London) ; Clarke, A. (University of Sussex) ; Leen, Clifford (The University of Edinburgh)
Introduction: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017. [...]
2022 - 10.1186/s12981-022-00457-0
AIDS Research and Therapy, Vol. 19 Núm. 1 (december 2022) , p. 38  
5.
14 p, 1.0 MB Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration : Randomized crossover clinical trial in healthy volunteers / Barroso, Sergio (Universitat Autònoma de Barcelona) ; Morén, Constanza (Universitat de Barcelona) ; González-Segura, Àlex (Universitat de Barcelona) ; Riba, Neus (Hospital Clínic i Provincial de Barcelona) ; Arnaiz, Joan A. (Hospital Clínic i Provincial de Barcelona) ; Manriquez, Marcela (Hospital Clínic i Provincial de Barcelona) ; Santana, Gemina (Hospital Clínic i Provincial de Barcelona) ; Blanco, José L. (Hospital Clínic i Provincial de Barcelona) ; Larousse, María (Hospital Clínic i Provincial de Barcelona) ; Loncà, Montse (Hospital Clínic i Provincial de Barcelona) ; de Lazzari, Elisa (Universitat de Barcelona) ; Llopis, Jaume (Universitat de Barcelona) ; Mallolas, Josep (Hospital Clínic i Provincial de Barcelona) ; Miró, Oscar (Hospital Clínic i Provincial de Barcelona) ; Carné, Xavier (Hospital Clínic i Provincial de Barcelona) ; Gatell, José M. (Hospital Clínic i Provincial de Barcelona) ; Garrabou, Glòria (Universitat de Barcelona) ; Martínez, Esteban (Hospital Clínic i Provincial de Barcelona)
Context Classical antiretroviral agents may acutely impact on metabolic, mitochondrial, renal and hepatic function in HIV-infected and uninfected persons. Fusion and integrase inhibitors are supposed to be safer, but have been scarcely investigated. [...]
2019 - 10.1371/journal.pone.0216712
PloS one, Vol. 14 Núm. 5 (may 2019) , p. e0216712  
6.
10 p, 1.7 MB IL-7/IL-7R gene variants impact circulating IL-7/IL-7R homeostasis and ART-associated immune recovery status / Ceausu, A. (Hospital Universitari Joan XXIII de Tarragona) ; Rodríguez-Gallego, Esther (Hospital Universitari Joan XXIII de Tarragona) ; Peraire, J. (Hospital Universitari Joan XXIII de Tarragona) ; López-Dupla, M. (Hospital Universitari Joan XXIII de Tarragona) ; Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ; Viladés, Consuelo (Hospital Universitari Joan XXIII de Tarragona) ; Vidal-Gonzalez, J. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Perpiñán, C. (Current address: Atenció Primària ICS. Cap Sant Pere) ; Pacheco, Yolanda M (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Veloso, S. (Hospital Universitari Joan XXIII de Tarragona) ; Alba, Verónica (Hospital Universitari Joan XXIII de Tarragona) ; Vargas, M. (Hospital Universitari Joan XXIII de Tarragona) ; Castellano, A. J. (Hospital Universitari Joan XXIII de Tarragona) ; Ruiz-Mateos, E. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Mallolas, Josep (Hospital Clínic i Provincial de Barcelona) ; Vidal, F. (Hospital Universitari Joan XXIII de Tarragona) ; Rull, A. (Hospital Universitari Joan XXIII de Tarragona) ; Universitat Autònoma de Barcelona
A relationship between polymorphisms in genes encoding interleukin 7 (IL-7) and its cellular receptor (IL-7R) and antiretroviral therapy (ART)-associated immune recovery in HIV subjects has been previously reported. [...]
2019 - 10.1038/s41598-019-52025-8
Scientific reports, Vol. 9 Núm. 1 (january 2019) , p. 15722  

Vea también: autores con nombres similares
3 Mallolas, Josep
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.